GlassScriptPhysician profile
Bipul Roy
NPI 1659539997
$2,444.26
in general payments reported to CMS, 2019-2025
27 companies · $23.20 in 2025
The $23.20 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $191 · 2021: $412 · 2022: $491 · 2023: $777 · 2024: $123 · 2025: $23.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917 · Education: $6.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.32 |
| Education | $6.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $369.49 | 2019-2023 | |
| Boston Scientific Corporation | $342.69 | 2019-2025 | Bodyguardian, Varithena Administration Pack, Watchman Flx |
| Astellas Pharma US INC | $198.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $184.02 | 2019-2022 | |
| Abbott Laboratories | $153.75 | 2021-2024 | Confirm Rx, Cardiomems |
| Novartis Pharmaceuticals Corporation | $149.42 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $132.92 | 2023-2024 | Optimizer, Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.55 | 2020-2024 | Jardiance |
| Kestra Medical Technology Services, INC. | $105.78 | 2022-2024 | Assure Wcd |
| Philips North America LLC | $96.27 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $81.66 | 2019-2023 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $76.44 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.43 | 2019-2022 | |
| Amgen INC. | $49.17 | 2019-2023 | Repatha |
| Irhythm Technologies, INC. | $43.68 | 2023 | Zio Xt Patch |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventice Services, LLC | $43.48 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $34.42 | 2021-2023 | Verquvo |
| Baxter Healthcare | $26.31 | 2019 | |
| Epi Health, LLC | $24.13 | 2020 | |
| Amarin Pharma, INC. | $21.24 | 2019 | |
| Sanofi-Aventis U.S. LLC | $20.76 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.42 | 2023 | |
| Heartflow, INC. | $19.93 | 2019 | |
| Esperion Therapeutics, INC. | $18.95 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $18.53 | 2019 | |
| Edwards Lifesciences Corporation | $17.64 | 2020 | |
| Alnylam Pharmaceuticals INC. | $17.18 | 2023 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bipul Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.